Exemed Pharmaceuticals, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is SERTRALINE HYDROCHLORIDE USP, with a corresponding US DMF Number 39432.
Remarkably, this DMF maintains an Active status since its submission on February 17, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 09, 2024, and payment made on August 01, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II